Cargando…
Current Multimodality Treatments against Brain Metastases from Renal Cell Carcinoma
SIMPLE SUMMARY: Brain metastasis (BM) is generally one of poor prognostic factors in patients with advanced renal cell carcinoma. However, because of longer control of extra-cranial disease by the recent introduction of molecular target therapy and immune checkpoint inhibitor, the incidence of BM ha...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600559/ https://www.ncbi.nlm.nih.gov/pubmed/33036276 http://dx.doi.org/10.3390/cancers12102875 |